Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124939722 | 12493972 | 2 | F | 2011 | 20160727 | 20160623 | 20160804 | EXP | US-ASTRAZENECA-2016SE66405 | ASTRAZENECA | 76.00 | YR | F | Y | 87.10000 | KG | 20160804 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124939722 | 12493972 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 80/4.5 MCG, 2 PUFFS TWICE A DAY | 2000354C00 | 21929 | BID | ||||||||
| 124939722 | 12493972 | 2 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 292200 | MG | 0 | 50 | MG | QID | ||||||
| 124939722 | 12493972 | 3 | C | LEVETIRACETAM (GENERIC KEPPRA) | 2 | Oral | 0 | 750 | MG | BID | |||||||||
| 124939722 | 12493972 | 4 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | Oral | 5000 UNITS ONCE A WEEK | 0 | CAPSULE | |||||||||
| 124939722 | 12493972 | 5 | C | BENZONATATE. | BENZONATATE | 1 | Oral | 0 | 200 | MG | TID | ||||||||
| 124939722 | 12493972 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 124939722 | 12493972 | 7 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 124939722 | 12493972 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 124939722 | 12493972 | 9 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 124939722 | 12493972 | 10 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 0 | 25 | MG | TID | ||||||||
| 124939722 | 12493972 | 11 | C | RANITIDINE. | RANITIDINE | 1 | Oral | 0 | 150 | MG | BID | ||||||||
| 124939722 | 12493972 | 12 | C | RANITIDINE. | RANITIDINE | 1 | Oral | 0 | 150 | MG | BID | ||||||||
| 124939722 | 12493972 | 13 | C | B-COMPLEX WITH FOLIC ACID AND VITAMIN C | 2 | Oral | 0 | 1 | DF | TABLET | QD | ||||||||
| 124939722 | 12493972 | 14 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Subcutaneous | ONCE A WEEK | 0 | INJECTION | |||||||||
| 124939722 | 12493972 | 15 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Subcutaneous | ONCE A WEEK | 0 | INJECTION | |||||||||
| 124939722 | 12493972 | 16 | C | FISH OIL | FISH OIL | 1 | Oral | 0 | 1000 | MG | BID | ||||||||
| 124939722 | 12493972 | 17 | C | SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S)) | HYPROMELLOSE 2910 (4000 MPA.S) | 1 | Intraocular | 2 DROPS EACH EYE ONCE DAILY OR AS NEEDED | 0 | ||||||||||
| 124939722 | 12493972 | 18 | C | SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S)) | HYPROMELLOSE 2910 (4000 MPA.S) | 1 | Intraocular | 2 DROPS EACH EYE ONCE DAILY OR AS NEEDED | 0 | ||||||||||
| 124939722 | 12493972 | 19 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124939722 | 12493972 | 1 | Chronic obstructive pulmonary disease |
| 124939722 | 12493972 | 2 | Hypertension |
| 124939722 | 12493972 | 3 | Seizure |
| 124939722 | 12493972 | 4 | Vitamin D deficiency |
| 124939722 | 12493972 | 5 | Cough |
| 124939722 | 12493972 | 6 | Cardiac disorder |
| 124939722 | 12493972 | 7 | Blood pressure abnormal |
| 124939722 | 12493972 | 8 | Cardiovascular event prophylaxis |
| 124939722 | 12493972 | 9 | Hypertension |
| 124939722 | 12493972 | 10 | Blood pressure abnormal |
| 124939722 | 12493972 | 11 | Dyspepsia |
| 124939722 | 12493972 | 12 | Gastrooesophageal reflux disease |
| 124939722 | 12493972 | 14 | Anaemia |
| 124939722 | 12493972 | 15 | Anaemia vitamin B12 deficiency |
| 124939722 | 12493972 | 16 | Cardiac disorder |
| 124939722 | 12493972 | 17 | Dry eye |
| 124939722 | 12493972 | 18 | Intraocular pressure increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124939722 | 12493972 | HO |
| 124939722 | 12493972 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124939722 | 12493972 | Asthma | |
| 124939722 | 12493972 | Cerebral haemorrhage | |
| 124939722 | 12493972 | Device malfunction | |
| 124939722 | 12493972 | Drug effect incomplete | |
| 124939722 | 12493972 | Internal haemorrhage | |
| 124939722 | 12493972 | Leukaemia | |
| 124939722 | 12493972 | Mental impairment | |
| 124939722 | 12493972 | Renal disorder | |
| 124939722 | 12493972 | Renal injury | |
| 124939722 | 12493972 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124939722 | 12493972 | 1 | 2008 | 0 | ||
| 124939722 | 12493972 | 2 | 2010 | 0 | ||
| 124939722 | 12493972 | 3 | 2014 | 0 | ||
| 124939722 | 12493972 | 4 | 201506 | 0 | ||
| 124939722 | 12493972 | 5 | 201601 | 0 | ||
| 124939722 | 12493972 | 6 | 2005 | 0 | ||
| 124939722 | 12493972 | 7 | 2005 | 0 | ||
| 124939722 | 12493972 | 8 | 2005 | 0 | ||
| 124939722 | 12493972 | 9 | 2006 | 0 | ||
| 124939722 | 12493972 | 11 | 2008 | 0 | ||
| 124939722 | 12493972 | 12 | 2008 | 0 | ||
| 124939722 | 12493972 | 13 | 2014 | 0 | ||
| 124939722 | 12493972 | 14 | 2014 | 0 | ||
| 124939722 | 12493972 | 15 | 2014 | 0 | ||
| 124939722 | 12493972 | 16 | 2010 | 0 | ||
| 124939722 | 12493972 | 17 | 2012 | 0 | ||
| 124939722 | 12493972 | 18 | 2012 | 0 | ||
| 124939722 | 12493972 | 19 | 2014 | 0 |